A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...

The trial was conducted across over 120 centres in 12 nations, including Canada, and regions across Asia and Europe.

The Scottish Medicines Consortium has announced its latest decisions on what new drugs can be used by the NHS in Scotland.

Join leading experts to discuss how we are ushering in a new era in bladder cancer care on May 28 virtually. Register now.

Congressman Greg Murphy, M.D., is recognizing May as Bladder Cancer Awareness Month. “While most bladder cancers are caught ...

In the POTOMAC study, one year of treatment with Imfinzi (durvalumab) plus standard-of-care BCG induction and maintenance ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi ...

Bill Russell and Jim Rieker are survivors. Both diagnosed with bladder cancer, the men have made it their mission to help ...

MAY IS BLADDER CANCER AWARENESS MONTH A TIME TO SHINE A LIGHT ON THIS OFTEN OVERLOOKED DISEASE THAT AFFECTS THOUSANDS OF PEOPLE EACH YEAR. JOINING ME NOW IS DOCTOR MURAD ABELARDO, A UROLOGIST WITH ...

Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...